BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 24909808)

  • 1. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives.
    Ianiro G; Bibbò S; Gasbarrini A; Cammarota G
    Curr Drug Targets; 2014; 15(8):762-70. PubMed ID: 24909808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial modulation of the gut microbiota.
    Walsh CJ; Guinane CM; O'Toole PW; Cotter PD
    FEBS Lett; 2014 Nov; 588(22):4120-30. PubMed ID: 24681100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in autism and mood disorders.
    Mangiola F; Ianiro G; Franceschi F; Fagiuoli S; Gasbarrini G; Gasbarrini A
    World J Gastroenterol; 2016 Jan; 22(1):361-8. PubMed ID: 26755882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Cammarota G; Ianiro G; Bibbò S; Gasbarrini A
    Intern Emerg Med; 2014 Jun; 9(4):365-73. PubMed ID: 24664520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics and antibiotics in IBD.
    Sokol H
    Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.
    Chassaing B; Koren O; Goodrich JK; Poole AC; Srinivasan S; Ley RE; Gewirtz AT
    Nature; 2015 Mar; 519(7541):92-6. PubMed ID: 25731162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and obesity: Pathogenetic relationships and ways to normalize the intestinal microflora].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(9):135-142. PubMed ID: 28635818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances in the gut microbiota and inflammation in obesity].
    Cao ZJ; Yu JC; Kang WM; Ma ZQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):462-5. PubMed ID: 23987498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.
    West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL;
    J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome, gut function, and probiotics: Implications for health.
    Hajela N; Ramakrishna BS; Nair GB; Abraham P; Gopalan S; Ganguly NK
    Indian J Gastroenterol; 2015 Mar; 34(2):93-107. PubMed ID: 25917520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and inflammation.
    Hakansson A; Molin G
    Nutrients; 2011 Jun; 3(6):637-82. PubMed ID: 22254115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbes and the brain: paradigm shift in neuroscience.
    Mayer EA; Knight R; Mazmanian SK; Cryan JF; Tillisch K
    J Neurosci; 2014 Nov; 34(46):15490-6. PubMed ID: 25392516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.